Status:
COMPLETED
A Proof of Concept Study of Serum Progesterone Levels for IVF/ICSI Following HCG Trigger for Oocyte Maturation
Lead Sponsor:
ART Fertility Clinics LLC
Conditions:
Infertility
Infertility, Female
Eligibility:
FEMALE
18-42 years
Brief Summary
This study will determine the rise of progesterone levels after human chorionic gonadotrophin (hCG) trigger in stimulated cycles IVF/ICSI
Detailed Description
Studies have suggested that controlled ovarian hyperstimulation adversely affects endometrial receptivity. In ovarian stimulation cycles with exogenous gonadotrophins there is an ongoing debate regard...
Eligibility Criteria
Inclusion
- Females aged 18 to 42 years with regular menstrual cycles of 26-34 days
- Undergoing ovarian stimulation for IVF/ICSI \& PGS.
- Receiving recombinant FSH for stimulation
- hCG 5000iu IM as trigger injection for oocyte maturation.
- Ovarian stimulation in GnRH-antagonist protocols
- BMI 18- 35 kg/m2
- Having 1 or 2 euploid embryos for transfer in spontaneous natural cycles.
Exclusion
- Poor ovarian reserve as defined by Bologna criteria
- PCOS in accordance with Rotterdam criteria
Key Trial Info
Start Date :
February 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04417569
Start Date
February 4 2021
End Date
June 30 2021
Last Update
February 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ART Fertility Clinics LLC
Abu Dhabi, United Arab Emirates, 60202